A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice-Reference-Cited by-同舟云学术

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice

Published:1999-03 Issue:9-10 Volume:17 Page:1223-1238
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Babai Ilan,Samira Sarit,Barenholz Yechezkel,Zakay-Rones Zichria,Kedar Eli

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference70 articles.

1. Murphy BR, Webster RG. Orthomyxoviruses. In: Fields BN, Knipe DM, Howley PM, et al., editors. Virology, 3rd ed. Philadelphia: Lippincott–Raven, 1996. p. 1397–1445

2. Influenza A and B virus infection in infants and young children during the years 1957–1976;Kim;Am J Epidemiol,1979

3. Impact of epidemic type A influenza in a defined adult population;Barker;Am J Epidemiol,1980

4. Failure of influenza vaccination in the aged;Keren;J Med Virol,1988

5. Kilbourne ED. Inactivated influenza vaccines. In: Plotkin A, Mortimer Jr. EA, editors. Vaccines. Philadelphia: Saunders, 1994. p. 565–81

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomes as Efficient Drug Delivery Vehicles to Combat Antimicrobial Resistance;Nanotechnology Based Strategies for Combating Antimicrobial Resistance;2024

2. Vaccine adjuvants and carriers;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

3. Common Nanocarriers and Their Advantages, Disadvantages and Applications;Highlights in Science, Engineering and Technology;2022-12-30

4. Nanovaccines to combat virus‐related diseases;WIREs Nanomedicine and Nanobiotechnology;2022-10-02

5. Depending on Epitope Profile of COVID-19 mRNA Vaccine Recipients: Are They More Efficient Against the Arising Viral Variants? An Opinion Article;Frontiers in Medicine;2022-06-20